GE HealthCare Technologies Inc.

NASDAQ:GEHC

Medical - Healthcare Information Services

Healthcare
$83.66 +0.74%

+$0.45 today

Market cap
$37.83B
Beta
0.86
P/E (TTM)
18.7
EPS (TTM)
$3.30
Dividend yield
0.23%
52W Low $58.75High $89.77

Volume 3.65M

Average 4.84M

GEHC Net Income

Bottom-line profit, the starting point for calculating cash from operations.

GE HealthCare Technologies Inc.NASDAQ: GEHC

Net Income · Q2 FY2026 · quarter ended Jun 2026

Net income growth accelerates

Q2 FY2026 net income of $574M rose 14.8% year over year, ahead of the -12.0% change in trailing-twelve-month net income. Sequentially, it rose 39.7% from the prior quarter. Over 3 fiscal years it compounded at +3.4% a year.

Context

  • Net income amounted to 10.4% of revenue in FY2025, unchanged from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 16 analysts of $2.31B (+7.4%) for the fiscal year ending Dec 2026, a step up from the +5.1% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$574M+39.7% QoQ
Last fiscal yearDec 2025
$2.15B+5.1% YoY
LTMJun 2026
$2.04B-12.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+14.8%+17.6%+2.8 pp
1 year+5.1%+7.4%+2.3 pp
3-year CAGR+3.4%+8.5%+5.2 pp
5-year CAGR+10.0%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
2.15B USD
Year-over-year change
+5.1%
4-year CAGR
-1.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How GEHC compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -12.0% is the 5th highest of 6, against a peer median of +27.8%.
  • Net income amounts to 10.1% of revenue for GEHC, versus a peer median of 14.0%.
GEHC Competitors
Net Income for GEHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ABTAbbott LaboratoriesLTM Jun 2026$5.43B USD-61.2%-2.0%11.6%
MDTMedtronic plcLTM Jul 2026$5.27B USD+12.7%+8.5%14.0%
SYKStryker CorporationLTM Jun 2026$3.73B USD+27.8%+11.2%14.4%
BSXBoston Scientific CorporationLTM Jun 2026$3.67B USD+34.6%+60.6%17.5%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$2.04B USD-12.0%+3.4%10.1%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.12B EUR+541.7%—6.3%
Peer median (excluding GEHC) —+27.8%+9.9%14.0%

Competitors are the stored peer set for GEHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income2.28B1.95B1.62B2.05B2.15B
Depreciation & Amortization625M633M610M580M578M
Deferred Income Tax600M563M743M531M0
Stock-Based Compensation76M67M114M125M130M
Change in Working Capital(1.37B)(293M)22M(59M)(357M)
Accounts Receivables(1.16B)(440M)(171M)(150M)(216M)
Inventory(435M)(402M)111M(81M)(142M)
Accounts Payables263M481M(13M)126M90M
Other Working Capital(42M)68M95M46M(89M)
Other Non-Cash Items(599M)(806M)(1.01B)(1.28B)(517M)
Operating Cash Flow1.61B2.11B2.1B1.95B1.99B
Capital Expenditures(248M)(310M)(387M)(401M)(482M)
Acquisitions (Net)(1.48B)0(147M)(313M)0
Purchases of Investments0(59M)(48M)(40M)(118M)
Sales of Investments00000
Other Investing Activities(32M)(29M)24M(160M)(447M)
Investing Cash Flow(1.76B)(398M)(558M)(914M)(1.05B)
Debt Repayment(12M)8.2B1.14B(423M)967M
Common Stock Issued00033M37M
Common Stock Repurchased0000(200M)
Dividends Paid00(41M)(55M)(64M)
Other Financing Activities(251M)(9.03B)(1.58B)(128M)(123M)
Financing Cash Flow(263M)(822M)(478M)(573M)617M
Effect of Forex Changes(34M)(3M)(10M)(77M)64M
Net Change in Cash(451M)890M1.06B387M1.62B
Free Cash Flow1.36B1.8B1.71B1.55B1.51B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

Intrinsic Alpha fair value

Locked

Current Price

$83.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.